Cover Image

Cyclooxygenase-2 expression in lung in patients with congenital heart malformations and pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a cause of morbidity in patients with congenital heart disease (CHD). It has been hypothesized that prostanoides participate in the development of PAH. The aim of this study was to show the potential expression of cyclooxygenase-2 (COX-2) in patients with CHD...

Full description

Saved in:
Bibliographic Details
Main Authors: Loukanov, Tsvetomir (Author) , Jaschinski, Christoph (Author) , Kirilov, Milen (Author) , Klimpel, Homa (Author) , Karck, Matthias (Author) , Gorenflo, Matthias (Author)
Format: Article (Journal)
Language:English
Published: 16 May 2013
In: The thoracic and cardiovascular surgeon
Year: 2013, Volume: 61, Issue: 4, Pages: 307-311
ISSN:1439-1902
DOI:10.1055/s-0033-1337446
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1055/s-0033-1337446
Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0033-1337446
Get full text
Author Notes:Tsvetomir Loukanov, Christoph Jaschinski, Milen Kirilov, Homa Klimpel, Matthias Karck, Matthias Gorenflo
Description
Summary:Pulmonary arterial hypertension (PAH) is a cause of morbidity in patients with congenital heart disease (CHD). It has been hypothesized that prostanoides participate in the development of PAH. The aim of this study was to show the potential expression of cyclooxygenase-2 (COX-2) in patients with CHD and PAH.
Item Description:Gesehen am 21.05.2021
Physical Description:Online Resource
ISSN:1439-1902
DOI:10.1055/s-0033-1337446

Similar Items